These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3591602)

  • 1. Thromboxane synthetase inhibition with CGS 13080 improves coronary blood flow after streptokinase-induced thrombolysis.
    Mickelson JK; Simpson PJ; Gallas MT; Lucchesi BR
    Am Heart J; 1987 Jun; 113(6):1345-52. PubMed ID: 3591602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined thromboxane A2 synthase inhibition and prostaglandin endoperoxide receptor antagonism limits myocardial infarct size after mechanical coronary occlusion and reperfusion at doses enhancing coronary thrombolysis by streptokinase.
    Vandeplassche G; Hermans C; Somers Y; Van de Werf F; de Clerck F
    J Am Coll Cardiol; 1993 Apr; 21(5):1269-79. PubMed ID: 8459087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of combined thromboxane synthase inhibition/receptor blockade with CGS 22652 in a canine model of coronary thrombosis.
    Olson RW; Dotson R; Mathis J; Cohen DS; Webb RL
    Eur J Pharmacol; 1993 May; 236(1):75-87. PubMed ID: 8319746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury.
    Simpson PJ; Smith CB; Rosenthal G; Lucchesi BR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):497-501. PubMed ID: 3735129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between platelet-derived 5-hydroxytryptamine and arachidonic acid metabolites limits the thrombolytic efficacy of streptokinase against canine platelet-rich coronary thrombosis.
    Vandeplassche G; Hermans C; Van Dael L; Wouters L; De Clerck F
    J Cardiovasc Pharmacol; 1993 Jan; 21(1):56-69. PubMed ID: 7678680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptokinase improves reperfusion blood flow after coronary artery occlusion.
    Mickelson JK; Simpson PJ; Lucchesi BR
    Int J Cardiol; 1989 Jun; 23(3):373-84. PubMed ID: 2737780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on lysis time and reocclusion rate after tissue plasminogen activator-induced coronary thrombolysis in the dog.
    Shebuski RJ; Smith JM; Storer BL; Granett JR; Bugelski PJ
    J Pharmacol Exp Ther; 1988 Aug; 246(2):790-6. PubMed ID: 3136245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary thrombolysis with intravenous streptokinase in the anesthetized dog: a dose-response study.
    Kopia GA; Kopaciewicz LJ; Ruffolo RR
    J Pharmacol Exp Ther; 1988 Mar; 244(3):956-62. PubMed ID: 3252043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced thrombolysis, reduced coronary reocclusion and limitation of infarct size with liposomal prostaglandin E1 in a canine thrombolysis model.
    Feld S; Li G; Amirian J; Felli P; Vaughn WK; Accad M; Tolleson TR; Swenson C; Ostro M; Smalling RW
    J Am Coll Cardiol; 1994 Nov; 24(5):1382-90. PubMed ID: 7930264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptokinase thrombolysis in experimental coronary artery thrombosis: pattern of reflow and effect of a stenosis.
    Schumacher WA; Buda AJ; Lucchesi BR
    Int J Cardiol; 1984 Nov; 6(5):615-27. PubMed ID: 6500751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolytic effects of intracoronary streptokinase on canine coronary artery thrombosis.
    Fiedler VB
    Basic Res Cardiol; 1984; 79(1):17-26. PubMed ID: 6732717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of inhibition of thrombin and blockade of thromboxane A2 synthetase and receptors enhances thrombolysis and delays reocclusion in canine coronary arteries.
    Yao SK; Ober JC; Ferguson JJ; Anderson HV; Maraganore J; Buja LM; Willerson JT
    Circulation; 1992 Dec; 86(6):1993-9. PubMed ID: 1451271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolysis in acute experimental myocardial infarction.
    Karsch KR; Hofmann M; Rentrop KP; Blanke H; Schaper W
    J Am Coll Cardiol; 1983 Feb; 1(2 Pt 1):427-35. PubMed ID: 6826954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A canine model of thrombin-induced coronary artery thrombosis: effects of intracoronary streptokinase on regional myocardial blood flow, contractile function, and infarct size.
    Warltier DC; Lamping KA; Pelc LR; Gross GJ
    J Pharmacol Methods; 1987 Dec; 18(4):305-18. PubMed ID: 3695539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet antibody [7E3 F(ab')2] prevents rethrombosis after recombinant tissue-type plasminogen activator-induced coronary artery thrombolysis in a canine model.
    Mickelson JK; Simpson PJ; Cronin M; Homeister JW; Laywell E; Kitzen J; Lucchesi BR
    Circulation; 1990 Feb; 81(2):617-27. PubMed ID: 2105175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of streptokinase-induced thrombolysis by heparin and prostacyclin.
    Schumacher WA; Lee EC; Lucchesi BR
    J Cardiovasc Pharmacol; 1985; 7(4):739-46. PubMed ID: 2410716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
    Przyklenk K; Kloner RA
    Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of hirudin and heparin as adjuncts to streptokinase thrombolysis in a canine model of coronary thrombosis.
    Rigel DF; Olson RW; Lappe RW
    Circ Res; 1993 May; 72(5):1091-102. PubMed ID: 8477521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DTTX30, a combined thromboxane receptor antagonist and thromboxane synthetase inhibitor, prevents coronary thrombosis in anesthetized dogs.
    Guth BD; Müller TH
    Basic Res Cardiol; 1997 Jun; 92(3):181-90. PubMed ID: 9226103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of salvage of reperfused ischemic myocardium by diltiazem.
    Knabb RM; Rosamond TL; Fox KA; Sobel BE; Bergmann SR
    J Am Coll Cardiol; 1986 Oct; 8(4):861-71. PubMed ID: 3489747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.